# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001640334-25-002275
Filing Date
2025-12-10
Accepted
2025-12-10 10:56:16
Documents
21
Period of Report
2026-01-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEF 14A | lxrp_def14a.htm iXBRL | DEF 14A | 486272
7 |  | lxrp_def14aimg20.jpg | GRAPHIC | 187890
8 |  | lxrp_def14aimg15.jpg | GRAPHIC | 6078
9 |  | lxrp_def14aimg16.jpg | GRAPHIC | 1376
10 |  | lxrp_def14aimg17.jpg | GRAPHIC | 1441
11 |  | lxrp_def14aimg18.jpg | GRAPHIC | 1371
12 |  | lxrp_def14aimg19.jpg | GRAPHIC | 10531
| Complete submission text file | 0001640334-25-002275.txt |  | 1371460

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | lxrp-20250831.xsd | EX-101.SCH | 4379
3 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | lxrp-20250831_lab.xml | EX-101.LAB | 12503
4 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | lxrp-20250831_cal.xml | EX-101.CAL | 1249
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | lxrp-20250831_pre.xml | EX-101.PRE | 8228
6 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | lxrp-20250831_def.xml | EX-101.DEF | 2449
23 | EXTRACTED XBRL INSTANCE DOCUMENT | lxrp_def14a_htm.xml | XML | 94684

Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: DEF 14A | Act: 34 | File No.: 001-39874 | Film No.: 251561149
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)